2012-05-31 15:04 Micropos Medical AB
2012-05-31 15:04 Micropos Medical AB
2012-05-24 17:44 Micropos Medical AB The award winning poster entitled "Time-resolved evolvement of target dose distribution during IMAT with and without dynamic MLC tracking" comes from the research that began in 2010 with the RayPilot® system in a collaboration between the Aarhus University Hospital in Denmark and Sydney Medical School in Australia.
2012-04-16 09:49 Isofol Medical AB Isofol Medical AB has received approval from the Swedish Medical Products Agency (Läkemedelsverket) to start a randomized phase I/II pharmacokinetic and pharmacodynamic study of its lead candidate Modufolin® in patients with colon cancer.
2011-11-21 16:02 Micropos Medical AB
2011-04-15 08:50 Isofol Medical AB Isofol Medical AB today announced that the company has enrolled its first patient in the explorative phase I/II trial, LARS2, for the treatment of rectal cancer. A total of 43 to 58 patients will receive Isofol’s novel folate-based drug Modufolin® in combination with the anti-cancer drug Alimta®.
2011-02-24 10:34 Isofol Medical AB Isofol Medical AB today announced that the Swedish Medical Products Agency has approved the use of Isofol Medical's newly produced vials of Modufolin® for clinical trials. This enables Isofol Medical to initiate its first clinical trial on humans, the LARS2 trial.
2010-03-09 22:58 GöteborgBIO Göteborgsregionen har idag en starkt växande biomedicinsk sektor genom bl a ett antal strategiska satsningar. GöteborgBIO arrangerar nu ett seminarium - ”Biomedicinska satsningar för framtiden – några nedslag” - där några av dessa spännande satsningar presenteras. Välkomna till en inspirerande framtidsdag!